Literature DB >> 25257626

Periventricular nodular heterotopia in Smith-Magenis syndrome.

Valeria Capra1, Roberta Biancheri, Giovanni Morana, Pasquale Striano, Francesca Novara, Giovanni Battista Ferrero, Luca Boeri, Maria Elena Celle, Maria Margherita Mancardi, Orsetta Zuffardi, Elena Parrini, Renzo Guerrini.   

Abstract

Smith-Magenis syndrome (SMS) is caused by an interstitial microdeletion of chromosome 17p11.2. A few patients with the typical SMS phenotype have RAI1 gene mutations. The syndrome is characterized by minor craniofacial anomalies, short stature, sleep disturbances, behavioural and neurocognitive abnormalities, as well as variable multisystemic manifestations. Periventricular nodular heterotopia (PNH) is a genetically heterogeneous neuronal migration disorder characterized by subependymal heterotopic nodules, and is variably associated with other brain malformations, epileptic seizures and intellectual disability. Here we report on two patients harboring deletions of the 17p11.2 region in whom the SMS typical phenotype was associated with bilateral PNH. Our observations expand the spectrum of chromosomal rearrangements associated with PNH and indicate that abnormal neuronal migration may contribute to the neurocognitive phenotype of SMS.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  17p11.2 chromosomal deletion; Periventricular nodular heterotopia (PNH); Smith-Magenis syndrome (SMS)

Mesh:

Year:  2014        PMID: 25257626     DOI: 10.1002/ajmg.a.36742

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  2 in total

Review 1.  Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes.

Authors:  Juanita Neira-Fresneda; Lorraine Potocki
Journal:  J Pediatr Genet       Date:  2015-09-28

Review 2.  Smith-Magenis Syndrome-Clinical Review, Biological Background and Related Disorders.

Authors:  Berardo Rinaldi; Roberta Villa; Alessandra Sironi; Livia Garavelli; Palma Finelli; Maria Francesca Bedeschi
Journal:  Genes (Basel)       Date:  2022-02-11       Impact factor: 4.096

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.